-
Mashup Score: 0Bayer snaps up digital imaging partner Blackford - - 2 year(s) ago
German pharma group Bayer makes another play in the digital medical imaging category, buying Blackford Analysis and its AI-based platform
Source: pharmaphorum.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3Digital monitoring could be a leveller in diabetes therapy - - 2 year(s) ago
Digitalhealth toolkit by Dario Health achieves improved blood sugar control in patients with type 2 diabetes, regardless of race or ethnicity
Source: pharmaphorum.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Digital monitoring could be a leveler in #diabetes therapy. How #digitalhealth and #selfcare unite to improve wellness and outcomes. https://t.co/AQ1xvI8OvQ via @pharmaphorum
-
-
Mashup Score: 3
With the currently popular approach to AI focussing on the Big Data paradigm, pharmaphorum spoke with Adityo Prakash, CEO of Verseon
Source: pharmaphorum.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @globaliqx: #AI and the #BigData paradigm – big ambitions in novel drug discovery https://t.co/8KyQopAB0f #eHealth #Innovation #Tech…
-
-
Mashup Score: 1Google and DeepMind share work on medical chatbot Med-PaLM - - 2 year(s) ago
Google and DeepMind develop artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers”
Source: pharmaphorum.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Google and DeepMind have developed Med-PaLM, an AI-powered chatbot to provide "safe and helpful" responses to inquiries by healthcare professionals and patients. Like #ChatGPT, it is a huge language model based on complex medical research datasets. https://t.co/jWY9TOE2Bd
-
-
Mashup Score: 0Study shows there is still a long way to go on trial diversity - - 2 year(s) ago
Study exposes lack of diversity in clinical trials underpinning new cancer drug approval in the US, but new metric from Bioethics could help
Source: pharmaphorum.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Study shows there is still a long way to go on trial diversity https://t.co/GkUu29HZb9
-
-
Mashup Score: 0Access solutions: the missing link that prevents biopharma innovation from reaching patients - - 3 year(s) ago
Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need.
Source: pharmaphorum.comCategories: Future of Medicine, Latest HeadlinesTweet-
Access solutions: the missing link that prevents biopharma innovation from reaching patients - https://t.co/HzkCB9LkCG https://t.co/u5wJWCZi5c
-
-
Mashup Score: 0
Digital health assistant Pahola developed by WHO and PAHO aims to cut burden of alcohol-related diseases and excessive drinking in Belize
Source: pharmaphorum.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@pahowho launch free #digitalhealth assistant to cut #alcohol-related diseases - https://t.co/tUhHakuYV4
-
-
Mashup Score: 0Evidence standard drawn up for digital therapeutics - - 3 year(s) ago
Digital Therapeutics Alliance and Curebase publish whitepaper on evidence standards for digital therapeutics
Source: pharmaphorum.comCategories: Future of Medicine, Latest HeadlinesTweet-
Evidence standard drawn up for digital therapeutics - https://t.co/misGTZeesK https://t.co/le1PKI6sGu
-
-
Mashup Score: 1
Digital health assistant Pahola developed by WHO and PAHO aims to cut burden of alcohol-related diseases and excessive drinking in Belize
Source: pharmaphorum.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
After the Florence 2.0 chatbot launched by the WHO recently, here is Pahola. Pahola is an AI-based #chatbot agent that can help patients cut alcohol-related diseases. It was launched in Belize as a part of a pilot. https://t.co/FQ9DKOFaEv
-
-
Mashup Score: 1
Myeloma Patients Europe (MPE) has identified significant inequalities among patients’ access to myeloma clinical trials in Central and Eastern
Source: pharmaphorum.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @DrGarethMorgan1: Huge inequalities found in access to myeloma clinical trials in Europe, says MPE. #mmsm https://t.co/VaBfEVRO6O
-
German pharma group Bayer has made another play in the digital medical imaging category, buying Blackford Analysis and its artificial intelligence-based platform for radiological assessments. https://t.co/1gO1YF81A6 https://t.co/itqoQATldR